Surgical cassette for intraocular pressure control
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 30 August 2026, 0.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
7 claims: 2 independent, 5 dependent
- 1Claims of equivalent WO 2007037900 A2 What is claimed is:1. A surgical cassette, comprising: a dual infusion chamber, said dual infusion chamber having a first chamber not fluidly coupled to said second chamber;a first fluid line fluidly coupled to said first chamber for providing an irrigating fluid to said first chamber;a second fluid line fluidly coupled to said first chamber for providing said irrigating fluid to a surgical device;a third fluid line fluidly coupled to said second chamber for providing said irrigating fluid to said second chamber;and a fourth fluid line fluidly coupled to said second chamber for providing said irrigating fluid to said surgical device.
- 5A surgical cassette, comprising:an infusion chamber having an upper surface and a lower surface;and a fluid line fluidly coupled to said infusion chamber for providing an irrigating fluid to said infusion chamber, said infusion chamber having an opening disposed near said lower surface for said fluid line.
Independent claims2
127 paragraphs in 1 section, as filed
Description of equivalent WO 2007037900 A2
SURGICAL CASSETTE FOR INTRAOCULAR PRESSURE CONTROL
0002Field of the Invention
0003The present invention generally pertains to microsurgical systems and more particularly to controlling intraocular pressure in ophthalmic surgery.
0004Description of the Related Art
0005During small incision surgery, and particularly during ophthalmic surgery, small
0006probes are inserted into the operative site to cut, remove, or otherwise manipulate tissue.
0007During these surgical procedures, fluid is typically infused into the eye, and the infusion fluid and tissue are aspirated from the surgical site.
0008Maintaining an optimum intraocular pressure during ophthalmic surgery is currently problematic. When no aspiration is occurring, the pressure in the eye becomes
0009the pressure of the fluid being infused into the eye. This pressure is typically referred to as the "dead head pressure". However, when aspiration is applied, the intraocular
0010pressure drops dramatically from the dead head pressure due to all the pressure losses in
0011the aspiration circuit associated with aspiration flow. Therefore, ophthalmic surgeons
0012currently tolerate higher than desired dead head pressures to compensate for occasions
0013when aspiration would otherwise lower the intraocular pressure to soft-eye conditions.
0014Clinically, such over-pressurizing of the eye is not ideal.
0015Accordingly, a need continues to exist for improved apparatus for controlling
0016intraocular pressure during ophthalmic surgery. Summary of the Invention
0017Ih one aspect, the present invention is a surgical cassette including a dual infusion
0018chamber and first through fourth fluid lines. The dual infusion chamber has a first chamber not fluidly coupled to the second chamber. The first fluid line is fluidly coupled to the first chamber and is for providing an irrigating fluid to the first chamber. The
0019second fluid line is fluidly coupled to the first chamber and is for providing the irrigating fluid to a surgical device. The third fluid line is fluidly coupled to the second chamber
0020and is for providing the irrigating fluid to the second chamber. The fourth fluid line is fluidly coupled to the second chamber and is for providing the irrigating fluid to the
0021surgical device.
0022In another aspect, the present invention is a surgical cassette including an infusion chamber and a fluid line. The infusion chamber has an upper surface and a lower surface.
0023The fluid line is fluidly coupled to the infusion chamber and is for providing an irrigating fluid to the infusion chamber. The infusion chamber has an opening disposed near the
0024lower surface for the fluid line.
0025Brief Description of the Drawings
0026For a more complete understanding of the present invention, and for further
0027objects and advantages thereof, reference is made to the following description taken in
0028conjunction with the accompanying drawings, in which:
0029Figure 1 is a schematic diagram illustrating infusion control in an ophthalmic
0030microsurgical system; Figure 2 is a schematic diagram illustrating infusion control and irrigation control
0031in an ophthalmic microsurgical system;
0032Figure 3 is a front, perspective view of a preferred surgical cassette for use in the
0033ophthalmic microsurgical system of Figures 1 and 2; and
0034Figure 4 is a front, perspective, partially fragmentary view of a dual infusion chamber of the surgical cassette of Figure 3.
0035Detailed Description of the Preferred Embodiments
0036The preferred embodiments of the present invention and their advantages are best understood by referring to Figures 1-4 of the drawings, like numerals being used for like
0037and corresponding parts of the various drawings. As shown in Figure 1, ophthalmic
0038microsurgical system 10 includes a pressure cuff 12; an infusion source 14; a dual infusion chamber 16 having a chamber 16a and a chamber 16b; fluid level sensors 18 and
003920; a flow sensor 22; filters 24 and 26; a surgical device 29; a computer or microprocessor 28; gas manifolds 30 and 32; a pressurized gas source 34; proportional
0040solenoid valves 36, 38, and 40; "on/off solenoid valves 42, 44, 46, 48, 50, 52, 54; actuators 56, 58, 60, and 62; and pressure transducers 64, 66, and 68. Dual infusion
0041chamber 16; fluid level sensors 18 and 20; portions of infusion fluid lines 70, 72, 74, 76, 78, and 80; and portions of gas lines 84 and 86 are preferably disposed in a surgical
0042cassette 27. Infusion source 14; dual infusion chamber 16;, flow sensor 22; filters 24 and
004326; and surgical device 29 are fluidly coupled via infusion fluid lines 70-80. Infusion
0044source 14, dual infusion chamber 16, gas manifolds 30 and 32; pressurized gas source 34; and actuators 56, 58, 60, and 62 are fluidly coupled via gas lines 82, 84, 86, 88, 90, 92, 94, and 96. Infusion source 14; fluid level sensors 18-20; flow sensor 22; microprocessor
004528; proportional solenoid valves 36-40; on/off solenoid valves 42-54; actuators 56-62; and pressure transducers 64-68 are electrically coupled via interfaces 100, 102, 104, 106,
0046108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, and 132.
0047Infusion source 14 is preferably a flexible infusion source. As shown best in Figures 3-4, dual infusion chamber 16 is preferably formed on a rear surface 27a of surgical cassette 27. Surgical cassette 27 preferably also has a top surface 27b and a
0048bottom surface 27c. Chambers 16a and 16b are preferably separated by a divider 16c, and
0049chambers 16a and 16b are not fluidly coupled. Dual infusion chamber 16 preferably also
0050has an upper surface 16d and a lower surface 16e. As shown best in Figures 1-2, chamber 16b has an opening 226 disposed on or near lower surface 16e for fluid line 74, and chamber 16a has an opening 228 disposed on or near lower surface 16e for fluid line 72.
0051As used in the context of the preceding sentence, "near" preferably means closer to lower
0052surface 16e than to a transverse plane passing through a midpoint between lower surface 16e and upper surface 16d, and "near" more preferably means closer to lower surface 16e than to a transverse plane passing through a point one quarter of the distance from lower
0053surface 16e and three quarters of the distance from upper surface 16d. Fluid level sensors
005418 and 20 may be any suitable device for measuring the level of fluid in infusion
0055chambers 16a and 16b, respectively. Fluid level sensors 18 and 20 are preferably capable of measuring the level of fluid in infusion chambers 16a and 16b in a continuous manner.
0056Flow sensor 22 may be any suitable device for measuring the flow rate of fluid within
0057fluid line 80. Flow sensor 22 is preferably a non-invasive flow sensor. Filters 24 and 26 are hydrophobic micro-bacterial filters. A preferred filter is the Versapor<sup>®</sup> membrane filter (0.8 micron) available from Pall Corporation of East Hills, New York.
0058Microprocessor 28 is capable of implementing feedback control, and preferably PID control. Surgical device 29 may be any suitable device for providing surgical irrigating
0059fluid to the eye but is preferably an infusion cannula, an irrigation handpiece, or and
0060irrigation/aspiration handpiece. The portions of fluid lines 70-80 disposed in surgical cassette 27, and the portions of gas lines 84-46 disposed in surgical cassette 27, may be any suitable line, tubing, or manifold for transporting a fluid but are preferably manifolds
0061integrally molded into surgical cassette 27.
0062In operation, fluid lines 70, 72, and 74; chambers 16a and 16b; fluid lines 76, 78,
0063and 80; and surgical device 29 are all primed with a surgical irrigating fluid 140 by pressurizing infusion source 14. Surgical irrigating fluid 140 may be any surgical irrigating fluid suitable for ophthalmic use, such as, by way of example, BSS PLUS®
0064intraocular irrigating solution available from Alcon Laboratories, hie.
0065The pressurizing of infusion source 14 is preferably performed by pressure cuff 12. More specifically, microprocessor 28 sends a control signal to open solenoid valve
006642 via interface 106 and to close solenoid valves 44 and 46 via interfaces 108 and 110, respectively. Microprocessor 28 also sends a control signal to open proportional solenoid
0067valve 40 via interface 104 so that manifold 30 supplies the appropriate amount of
0068pressurized air to actuate pressure cuff 12. Pressure transducer 68 senses the pressure
0069within gas line 82 and provides a corresponding signal to microprocessor 28 via interface 126. Solenoid valves 48-54 are initially open so that manifold 32 provides pressurized air
0070to actuate actuators 56-62 to close fluid lines 72-78. Microprocessor 28 sends control
0071signals to close solenoid valves 48-54 via interfaces 114-120. The closing of solenoid valves 48-54 actuates actuators 56-62 to open fluid lines 72-78. After all chambers and
0072fluid lines are primed, microprocessor 28 closes actuators 56-62 and thus fluid lines 72-
007378. Alternatively, the pressuring of infusion source 14 may be performed solely via gravity.
0074After priming, a user then provides a desired intraocular pressure to
0075microprocessor 28 via an input 134. Input 134 may be any suitable input device but is preferably a touch screen display or physical knob. Chamber 16b is preferably the initial
0076active infusion chamber. Microprocessor 28 sends appropriate control signals to open solenoid valve 44 and to open proportional solenoid valve 36 (via interface 100) to
0077provide an appropriate level of pressurized air to chamber 16b. Pressure transducer 64
0078senses the pressure within gas line 84 and provides a corresponding signal to microprocessor 28 via interface 124. Microprocessor 28 also sends an appropriate control
0079signal to open actuator 60 and thus fluid line 78. Chamber 16b supplies pressurized fluid 140 to the eye via fluid lines 78 and 80 and surgical device 29. Flow sensor 22 measures
0080the flow rate of fluid 140 and provides a corresponding signal to microprocessor 28 via interface 132. Microprocessor 28 calculates a predicted intraocular pressure using the
0081signal from flow sensor 22 and empirically determined impedance information of microsurgical system 10. Microprocessor 28 then sends an appropriate feedback control
0082signal to proportional solenoid valve 36 to maintain the predicted intraocular pressure at
0083or near the desired intraocular pressure during all portions of the surgery.
0084Fluid level sensor 20 continuously monitors the decrease in the level of fluid 140
0085in chamber 16b during surgery and provides a corresponding signal to microprocessor 28
0086via interface 130. Microprocessor 28 performs adjustments to the air pressure provided to chamber 16b to accommodate for the difference in fluid head height as the level of
0087fluid 140 decreases. When the level of fluid 140 in chamber 16b reaches a bottom limit
0088level, microprocessor 28 closes solenoid valve 44 and actuator 60 and opens solenoid valve 46 and actuators 58 and 62. Chamber 16a is now the active infusion chamber. Microprocessor 28 sends an appropriate control signal to proportional solenoid valve 38
0089via interface 102 to provide an appropriate level of pressurized air to chamber 16a.
0090Pressure transducer 66 senses the pressure within gas line 86 and provides a
0091corresponding signal to microprocessor 28 via interface 122. Chamber 16a supplies pressurized fluid 140 to the eye via fluid lines 76 and 80 and surgical device 29. Flow
0092sensor 22 measures the flow rate of fluid 140 and provides a corresponding signal to microprocessor 28 via interface 132. Microprocessor 28 calculates the predicted
0093intraocular pressure as described above and the sends an appropriate feedback signal to proportional solenoid valve 38 to maintain the predicted intraocular pressure at or near the desired intraocular pressure during all portions of the surgery. Microprocessor 28
0094closes actuator 58 and fluid line 74 once chamber 16b is refilled with fluid 140.
0095Fluid level sensor 18 continuously monitors the decrease in the level of fluid 140
0096in chamber 16a during surgery and provides a corresponding signal to microprocessor 28 via interface 128. Microprocessor 28 performs adjustments to the air pressure provided
0097to chamber 16a to accommodate for the difference in fluid head height as the level of
0098) fluid 140 decreases. When the level of fluid 140 in chamber 16a reaches a bottom limit
0099level, microprocessor 28 switches chamber 16b to active infusion, makes chamber 16a
0100inactive, and refills chamber 16a with fluid 140 via fluid line 72. This cycling between chambers 16b and 16a continues throughout the surgery. Infusion source 14 is preferably monitored via a fluid level sensor (not shown) capable of providing a signal to microprocessor 28 via interface 112 when source 14
0101reaches a near empty limit. Chambers 16a and 16b also preferably each have a volume
0102that enable infusion source 14 to be exchanged, when near empty, without interrupting the surgical procedure. More specifically, chambers 16a and 16b preferably each have a
0103volume of about 30 cc. Such volume allows about two minutes for a near empty infusion source 14 to be exchanged during conditions of maximum flow (e.g. core vitrectomy). In
0104addition, since fluid lines 72 and 74 are fluidly coupled to chambers 16a and 16b,
0105respectively, at or near lower surface 16e, once infusion source 14 is exchanged all air bubbles within fluid lines 70, 72, and 74 will be automatically "scrubbed out" as the
0106inactive chamber 16a or 16b refills, without the need for re-priming.
0107In the case of failure of either of chambers 16a or 16b, microprocessor 28 can preferably continue surgery with only one active chamber. In the case of failure of both
0108chambers 16a and 16b, microprocessor 28 can preferably continue surgery using only infusion source 14.
0109Figure 2 shows a modified ophthalmic microsurgical system 10a. Microsurgical
0110system 10a is similar to microsurgical system 10 except that it has an irrigation system in
0111addition to the infusion system described above for system 10. More specifically, system
011210a is identical to system 10 except that system 10a also includes an irrigation source 200; fluid lines 202 and 206; gas lines 208 and 216; solenoid valves 210 and 218 ;
0113actuators 214 and 222; electrical interfaces 212 and 220; and a surgical device 224. As
0114shown in Figure 2, irrigation source 200 is pressurized solely by gravity. The portions of fluid lines 202 and 206 disposed in surgical cassette 27, and the portions of gas lines 208 and 216 disposed in surgical cassette 27, may be any suitable line, tubing, or manifold for transporting a fluid but are preferably manifolds integrally molded into surgical cassette
011527. As will be appreciated by one of ordinary skill in the art, microsurgical system 10a
0116allows surgical irrigating fluid 140 to be delivered to surgical device 29 via fluid line 80 (infusion), and surgical irrigating fluid 140 to be delivered to surgical device 224 via fluid
0117line 206 (irrigation), independently. Microprocessor 28 can calculate flow information
0118for fluid 140 within fluid line 206 by continuously monitoring the volumetric change of fluid inside chamber 16b, as indicated by fluid sensor 20.
0119From the above, it may be appreciated that the present invention provides an
0120improved method of controlling intraocular pressure with a microsurgical system. The present invention is illustrated herein by example, and various modifications may be made by a person of ordinary skill in the art. For example, while the present invention is
0121described above relative to controlling intraocular pressure in an ophthalmic
0122microsurgical system, it is also applicable to controlling pressure within the operative
0123tissue during other types of microsurgery.
0124It is believed that the operation and construction of the present invention will be
0125apparent from the foregoing description. While the apparatus and methods shown or described above have been characterized as being preferred, various changes and
0126modifications may be made therein without departing from the spirit and scope of the
0127) invention as defined in the following claims
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO03079927A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US2003208155A1 | Cites | United States of America | Search report |
| US2004204679A1 | Cites | United States of America | Search report |
| US6485451B1 | Cites | United States of America | Search report |
| WO9117112A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO9427659A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
40 members in 21 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 237568 | United States of America | – | |
| 23756805 | United States of America | A | |
| 2006033909 | United States of America | W |
Members40
| Document | Office | Kind | |
|---|---|---|---|
| US2007073234A1 | United States of America | A1 | |
| AU2006295262A1 | Australia | A1 | |
| CA2620367A1 | Canada | A1 | |
| WO2007037900A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW200722067A | Taiwan Province of China | A | |
| WO2007037900A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AR058672A1 | Argentina | A1 | |
| MX2008003013A | Mexico | A | |
| KR20080056214A | Republic of Korea | A | |
| EP1960032A2This record | European Patent Office (EPO) | A2 | |
| CN101384296A | China | A | |
| JP2009509633A | Japan | A | |
| EP1960032A4 | European Patent Office (EPO) | A4 | |
| RU2008116572A | Russian Federation | A | |
| US7713237B2 | United States of America | B2 | |
| US2010228199A1 | United States of America | A1 | |
| EP1960032B1 | European Patent Office (EPO) | B1 | |
| AT491495T | Austria | T | |
| ATE491495T1 | Austria | T1 | |
| DK1960032T3 | Denmark | T3 | |
| DE602006018992D1 | Germany | D1 | |
| EP2286851A2 | European Patent Office (EPO) | A2 | |
| PT1960032E | Portugal | E | |
| US7896839B2 | United States of America | B2 | |
| ES2356561T3 | Spain | T3 | |
| SI1960032T1 | Slovenia | T1 | |
| RU2421196C2 | Russian Federation | C2 | |
| EP2286851A3 | European Patent Office (EPO) | A3 | |
| EP1960032B9 | European Patent Office (EPO) | B9 | |
| PL1960032T3 | Poland | T3 | |
| AU2006295262B2 | Australia | B2 | |
| CN101384296B | China | B | |
| BRPI0616435A2 | Brazil | A2 | |
| KR101223992B1 | Republic of Korea | B1 | |
| JP5209483B2 | Japan | B2 | |
| TWI401067B | Taiwan Province of China | B | |
| CA2620367C | Canada | C | |
| CY1111888T1 | Cyprus | T1 | |
| BRPI0616435B1 | Brazil | B1 | |
| BRPI0616435B8 | Brazil | B8 |
113 legal events, as 22 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Transfer of patentPC2A | PC2A | ES | |
| Change of ownershipPD | PD | BE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20200123 AND 20200129732E | 732E | GB | |
| AssignmentPUE | PUE | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Change of ownershipPD | PD | NL | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapse of patentLapsedKO00 | KO00 | SI | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsed due to non-payment of maintenance feesLapsedMM4A | MM4A | SK | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapse because of not paying annual feesLapsedMM01 | MM01 | AT | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapse european patentLapsedMM4D | MM4D | LT | |
| Lapsed by not paying the annual feesLapsedMM4A | MM4A | EE | |
| Fee paymentPLFP | PLFP | FR | |
| New agentNV | NV | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Change of ownershipPD | PD | BE | |
| Transmission of propertyTP | TP | FR | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20171102 AND 20171108732E | 732E | GB | |
| Transfer of patentPC2A | PC2A | ES | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Appointment of representativeFH1C | FH1C | HU | |
| Succession in titleGB9C | GB9C | HU | |
| MergerPFUS | PFUS | CH | |
| Change of ownershipPD | PD | LU | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Change in the ownership or in the address of the ownerGB1A | GB1A | EE | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Translation of ep patentT3 | T3 | PL | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Translation of european patent specification into slovakT3 | T3 | SK | |
| Ep patent validated in greeceEP | EP | GR | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3 | T3 | NL | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Ep patent valid in romaniaEPE | EPE | RO | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Corresponds to:REF | REF | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| New agentNV | NV | CH |
Numbers
- Publication
- 1960032
- Application
- 67901017
Titles3
- German
- CHIRURGISCHE KASSETTE FÜR DIE INTRAOKULARE DRUCKKONTROLLE
- English
- SURGICAL CASSETTE FOR INTRAOCULAR PRESSURE CONTROL
- French
- CASSETTE CHIRURGICALE DE MESURE DE LA TENSION INTRAOCULAIRE
Classification
- CPC, 14
- A61M3/0258
- A61M37/00
- A61M2205/12
- A61M2205/3331
- A61M2205/3389
- A61M2210/0612
- A61M2205/50
- A61M3/0216
- A61M3/0208
- A61M3/0212
- A61M3/022
- A61M2205/3344
- A61M1/77
- A61M3/0201
- IPC, 1
- A61M37 00
Designated states31
- Contracting states, 31
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Netherlands (Kingdom of the)
and 7 moreShow fewer
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye